Oxford new crown vaccine approved in the UK According to a BBC report on December 30, the British drug regulatory agency approved the new crown vaccine jointly developed by Oxford University and AstraZeneca. According to the previously announced Phase III clinical trial results, the average effectiveness of the vaccine reached 70%. Berichten zufolge, the British government has ordered 100 …